Optomed Oyj (HEL:OPTOMED)

Market Cap	30.73M -62.3%
Revenue (ttm)	16.43M +4.4%
Net Income	-6.16M
EPS	-0.31
Shares Out	21.43M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,671
Open	1.440
Previous Close	1.434
Day's Range	1.440 - 1.498
52-Week Range	1.332 - 4.745
Beta	1.54
Analysts	Hold
Price Target	2.40 (+63.04%)
Earnings Date	Aug 14, 2026

About Optomed Oyj

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2004
• Employees: 110
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: OPTOMED

Financial Performance

In 2025, Optomed Oyj's revenue was 17.10 million, an increase of 13.67% compared to the previous year's 15.04 million. Losses were -6.64 million, 21.8% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for OPTOMED stock is "Hold." The 12-month stock price target is €2.40, which is an increase of 63.04% from the latest price.

Price Target

€2.40

(63.04% upside)

Analyst Consensus: Hold